BRENTWOOD, Tenn., May 12, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical…
First Quarter Chubbies Segment Sales up 43.9% and Solo Stove Sales Down, as Expected, to Realign Go-to-Market Strategy; Solid Evidence…
First Cohort Completed in PRECISE-AD Trial Evaluating PMN310 in Alzheimer’s Disease Six Month Interim Results Expected in 1H 2026 Topline…
Underreported D.E.A. Letter and Policy Position Could be a Game Changer for Mushroom Enthusiasts An Emerging Markets Sponsored Commentary ORLANDO,…
Dorel Juvenile reports strong performanceDorel Home taking further steps to return to profitability MONTRÉAL, May 12, 2025 (GLOBE NEWSWIRE) --…
First Quarter 2025 Highlights Revenue increased 17% to €311 millionProfit for the period increased to €24 million and expanded to…
MET-097i, a fully biased, monthly, ultra-long acting GLP-1 receptor agonist, is in three ongoing VESPER Phase 2b trials, with data…
Mike Heffernan appointed as Chairman of the Board Topline data from Phase 2 LOTUS trial of AVTX-009 for the treatment…
Phase 1 dosing completed for NBD1 stabilizers SION-719 & SION-451; both compounds continue to be generally well tolerated Phase 1…
– Data update from ongoing TNG462 Phase 1/2 monotherapy trial expected 2H 2025 – – Combination trial of TNG462 + Revolution…
This website uses cookies.